for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

InfuSystem Holdings Inc

INFU.N

Latest Trade

11.13USD

Change

0.00(0.00%)

Volume

100

Today's Range

--

 - 

--

52 Week Range

4.50

 - 

12.95

As of on the NYSE MKT LLC ∙ Minimum 15 minute delay

Pricing

Previous Close
11.13
Open
0.00
Volume
100
3M AVG Volume
2.64
Today's High
--
Today's Low
--
52 Week High
12.95
52 Week Low
4.50
Shares Out (MIL)
20.07
Market Cap (MIL)
224.18
Forward P/E
159.57
Dividend (Yield %)
--

Latest Developments

More

Infusystem Holdings Reports First Quarter 2020 Financial Results

Infusystem Holdings Posts Qtrly EPS $0.04

Infusystem Retains Heidrick & Struggles For Nationwide CFO Search Appoints Interim CFO

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About InfuSystem Holdings Inc

InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.

Industry

Medical Equipment & Supplies

Contact Info

31700 Research Park Dr

MADISON HEIGHTS, MI

48071-4627

United States

+1.248.2911210

https://ir.infusystem.com/

Executive Leadership

Scott A. Shuda

Independent Chairman of the Board

Richard A. Diiorio

President, Chief Executive Officer, Director

Barry G. Steele

Chief Financial Officer, Executive Vice President

Carrie Lachance

Chief Operating Officer

Thomas Ruiz

Senior Vice President of Sales and Marketing

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2020(E)

0.1K
EPS (USD)

2020(E)

0.070
Price To Earnings (TTM)
125.14
Price To Sales (TTM)
2.65
Price To Book (MRQ)
10.16
Price To Cash Flow (TTM)
15.09
Total Debt To Equity (MRQ)
179.93
LT Debt To Equity (MRQ)
146.80
Return on Investment (TTM)
3.54
Return on Equity (TTM)
2.54

Latest News

Latest News

BRIEF-InfuSystem To Join FTSE Russell 2000 Index

* INFUSYSTEM HOLDINGS - ADDITION TO FTSE RUSSELL 2000 INDEX EFFECTIVE AFTER MARKET CLOSES ON JUNE 26 Source text for Eikon: Further company coverage:

BRIEF-Infusystem Holdings Reports First Quarter 2020 Financial Results

* INFUSYSTEM HOLDINGS, INC. REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

BRIEF-Infusystem Holdings Says Net Revenues For Q1 Of 2020 Were $21.6 Mln, Up 18% From Same Prior Year Period

* INFUSYSTEM HOLDINGS INC - NET REVENUES FOR Q1 OF 2020 WERE $21.6 MILLION, AN INCREASE OF 18% FROM SAME PRIOR YEAR PERIOD

BRIEF-Infusystem Holdings Posts Qtrly EPS $0.04

* INFUSYSTEM HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

BRIEF-InfuSystem Names Barry G. Steele As New Chief Financial Officer

* INFUSYSTEM NAMES BARRY G. STEELE AS NEW CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage:

BRIEF-Infusystem Enters Negative Pressure Wound Therapy Market

* INFUSYSTEM ENTERS NEGATIVE PRESSURE WOUND THERAPY MARKET Source text for Eikon: Further company coverage:

BRIEF-Infusystem Retains Heidrick & Struggles For Nationwide CFO Search Appoints Interim CFO

* INFUSYSTEM RETAINS HEIDRICK & STRUGGLES FOR NATIONWIDE CFO SEARCH; APPOINTS INTERIM CFO

BRIEF-InfuSystem Holdings Reports Q1 Earnings Per Share $0.01

* INFUSYSTEM HOLDINGS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Ryan J. Morris Reports 4.7 pct Stake In Infusystem Holdings As Of March 19

* RYAN J. MORRIS REPORTS 4.7 PERCENT STAKE IN INFUSYSTEM HOLDINGS INC AS OF MARCH 19, 2018 - SEC FILING

BRIEF-Infusystem Holdings Reports Q4 Loss Per Share $0.79

* INFUSYSTEM HOLDINGS, INC. REPORTS FOURTH QUARTER AND FISCAL YEAR 2017 RESULTS

BRIEF-Infusystem Holdings Reports Interim CFO Will Leave Co At End Of Current Quarter

* INFUSYSTEM HOLDINGS, INC. REPORTS INTERIM CHIEF FINANCIAL OFFICER WILL LEAVE COMPANY AT END OF CURRENT QUARTER

BRIEF-Richard Diiorio appointed as president and CEO of Infusystem Holdings

* Richard Diiorio appointed as president and chief executive officer of Infusystem Holdings, Inc.

BRIEF-InfuSystem Holdings Q3 loss per share $0.01

* InfuSystem Holdings Inc reports third quarter 2017 financial results

BRIEF-InfuSystem Holdings Inc Q2 loss per share $0.05

* InfuSystem Holdings Inc reports second quarter 2017 financial results

BRIEF-InfuSystem announces amendment to existing credit facility with JPMorgan Chase

* InfuSystem announces amendment to existing credit facility with JPMorgan Chase

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up